Literature DB >> 27707006

Background and episodic breathlessness in advanced cancer patients followed at home.

Sebastiano Mercadante1, Flavio Fusco2, Amanda Caruselli3, Claudio Cartoni4, Francesco Masedu5, Marco Valenti5, Federica Aielli5.   

Abstract

BACKGROUND: The aim of this study was to assess the phenomenon of episodic breathlessness in advanced cancer patients followed by palliative care services at home.
METHODS: A consecutive sample of patients with advanced cancer, admitted to home care for a period of six months, was surveyed. The presence of background breathlessness and episodic breathlessness, their intensity, and drugs used for their treatment were collected. Factors inducing episodic breathlessness, and its influence on daily activities were investigated.
RESULTS: Three hundred forty-seven advanced cancer patients admitted to home palliative care were surveyed. The prevalence of breathlessness was 35.3%. The mean intensity of breathlessness was 3.8 (SD 1.96), out of a maximum score of 10 for worst imaginable. Sixty patients (49.2%) were receiving drugs for background breathlessness. In the multivariate analysis the risk of breathlessness increased with cardiovascular disease, chronic obstructive pulmonary disease, and lung cancer while it decreased in patients with a better performance status. The prevalence of episodic breathlessness in patients with background breathlessness was 79.5% and its mean intensity was 7.1 (SD 1.5, range 2-10). The mean duration of episodic breathlessness was 28.6 minutes (SD 47.1, range 1-300 minutes). Forty-three patients (44.3%) were receiving one or more drugs as needed. The majority of episodic breathlessness events were triggered by activity. Episodic breathlessness was interfering with daily activities in 65 patients (67%). Episodic breathlessness wasn't associated with any variable taken into consideration.
CONCLUSION: This study showed that episodic breathlessness frequently occurs in advanced cancer patients admitted to home care, is severe in intensity, is triggered in most cases by activity, and is characterized by a short duration which requires rapid measures.

Entities:  

Keywords:  Advanced cancer; dyspnea; episodic breathlessness; home care; opioids; palliative care

Mesh:

Year:  2016        PMID: 27707006     DOI: 10.1080/03007995.2016.1240668

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  3 in total

Review 1.  Episodic Breathlessness in Patients with Advanced Cancer: Characteristics and Management.

Authors:  Sebastiano Mercadante
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

2.  Polypharmacy Increases Risk of Dyspnea Among Adults With Serious, Life-Limiting Diseases.

Authors:  Kathleen M Akgün; Supriya Krishnan; Shelli L Feder; Janet Tate; Jean S Kutner; Kristina Crothers
Journal:  Am J Hosp Palliat Care       Date:  2019-09-24       Impact factor: 2.500

3.  Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults.

Authors:  Alison Haywood; Jacqueline Duc; Phillip Good; Sohil Khan; Kirsty Rickett; Petra Vayne-Bossert; Janet R Hardy
Journal:  Cochrane Database Syst Rev       Date:  2019-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.